Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: A retrospective population-based study

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Ray, Gary Thomas ^a   Suaya, Jose Antonio ^b   Baxter, Roger ^c  

^a DIVISION OF RESEARCH   (United States)

^b GLAXOSMITHKLINE   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Incidence; Methicillin resistant staphylococcus aureus; Skin and soft tissue infections

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; ASIAN; BACTERIAL SKIN DISEASE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CARBUNCLE; CAUCASIAN; CELLULITIS; CLINICAL FEATURE; COMMUNICABLE DISEASE; DIABETIC PATIENT; ETHNIC DIFFERENCE; FEMALE; FOLLICULITIS; FURUNCULOSIS; HISPANIC; HUMAN; IMPETIGO; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; POPULATION BASED CASE CONTROL STUDY; PUBLIC HEALTH PROBLEM; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SKIN ABSCESS; SOFT TISSUE INFECTION;

ADOLESCENT; ADULT; AGED; BACTERIA; CALIFORNIA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; UNITED STATES; YOUNG ADULT;

EID: 84878239968     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-252     Document Type: Article

References (56)

1. Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol 2008, 19:173-184. 2605859, 19352449.
2. Dryden M. Complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: epidemiology, risk factors, and presentation. Surg Infect (Larchmt) 2008, 9(Suppl 1):s3-10.
3. Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003, 52(Suppl 1):i3-i17.
4. Dryden MS. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009, 34(Suppl 1):S2-S7.
5. Vinh DC, Embil JM. Rapidly progressive soft tissue infections. Lancet Infect Dis 2005, 5:501-513. 10.1016/S1473-3099(05)70191-2, 16048719.
6. Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore) 2010, 89:217-226.
7. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007, 57:7-13. 10.1016/j.diagmicrobio.2006.05.009, 17059876.
8. Zilberberg MD, Shorr AF, Micek ST, Hoban AP, Pham V, Doherty JA, Ramsey AM, Kollef MH. Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors. Infect Control Hosp Epidemiol 2009, 30:1203-1210. 10.1086/648083, 19848604.
9. Rennie RP, Jones RN, Mutnick AH. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis 2003, 45:287-293. 10.1016/S0732-8893(02)00543-6, 12730001.
10. Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clin Infect Dis 2010, 51:895-903. 10.1086/656431, 20839951.
11. Lipsky BA, Weigelt JA, Gupta V, Killian A, Peng MM. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 2007, 28:1290-1298. 10.1086/520743, 17926281.
12. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436-1444. 10.1056/NEJMoa043252, 15814879.
13. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007, 13:1840-1846. 10.3201/eid1312.070629, 2876761, 18258033.
14. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771. 10.1001/jama.298.15.1763, 17940231.
15. Shorr AF. Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature. Pharmaco Economics 2007, 25:751-768.
16. Dietrich DW, Auld DB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics 2004, 113:e347-e352. 10.1542/peds.113.4.e347, 15060266.
17. Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001, 184:1029-1034. 10.1086/323459, 11574918.
18. Miller LG, Kaplan SL. Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am 2009, 23:35-52. 10.1016/j.idc.2008.10.002, 19135915.
19. Crum NF, Lee RU, Thornton SA, Stine OC, Wallace MR, Barrozo C, Keefer-Norris A, Judd S, Russell KL. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006, 119:943-951. 10.1016/j.amjmed.2006.01.004, 17071162.
20. Farley JE. Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Nurse Pract 2008, 20:85-92. 10.1111/j.1745-7599.2007.00290.x, 2688639, 18271763.
21. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006, 144:309-317. 10.7326/0003-4819-144-5-200603070-00005, 16520471.
22. Adam HJ, Allen VG, Currie A, McGeer AJ, Simor AE, Richardson SE, Louie L, Willey B, Rutledge T, Lee J, et al. Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors. CJEM 2009, 11:439-446.
23. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008, 51:291-298. 10.1016/j.annemergmed.2007.12.004, 18222564.
24. McCaig LF, McDonald LC, Mandal S, Jernigan DB. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis 2006, 12:1715-1723. 10.3201/eid1211.060190, 3372331, 17283622.
25. Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, Spalding J, Jiang J, Oster G. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009, 15:1516-1518. 10.3201/eid1509.081228, 2819854, 19788830.
26. Saxena S, Thompson P, Birger R, Bottle A, Spyridis N, Wong I, Johnson AP, Gilbert R, Sharland M. Increasing skin infections and Staphylococcus aureus complications in children, England, 1997-2006. Emerg Infect Dis 2010, 16:530-533. 10.3201/eid1603.090809, 3322014, 20202439.
27. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010, 304:641-648. 10.1001/jama.2010.1115, 20699455.
28. Diamantis ML, Ortega-Loayza AG, Morrell DS. Update on the characterization of Staphylococcus aureus skin infections in a pediatric dermatology tertiary health care outpatient facility: antibiotic susceptibility patterns and decreased methicillin resistance. J Am Acad Dermatol 2011, 64:440-441. 10.1016/j.jaad.2010.06.057, 21238834.
29. Ray GT, Suaya JA, Baxter R. Trends and characteristics of culture-confirmed staphylococcus aureus infections in a large U.S. Integrated health care organization. J Clin Microbiol 2012, 50:1950-1957. 10.1128/JCM.00134-12, 3372166, 22422853.
30. Mera RM, Suaya JA, Amrine-Madsen H, Hogea CS, Miller LA, Lu EP, Sahm DF, O'Hara P, Acosta CJ. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb Drug Resist 2011, 17:321-328. 10.1089/mdr.2010.0193, 21417776.
31. Ellis Simonsen SM, van Orman ER, Hatch BE, Jones SS, Gren LH, Hegmann KT, Lyon JL. Cellulitis incidence in a defined population. Epidemiol Infect 2006, 134:293-299. 2870381, 16490133.
32. Gordon NP. Similarity of the Adult Kaiser Permanente Membership in Northern California to the Insured and General Population in Northern California. Statistics from the 2007 California Health Interview Survey 2012, Oakland, CA, http://www.dor.kaiser.org/external/chis_non_kp_2007/.
33. Elliott MN, Fremont A, Morrison PA, Pantoja P, Lurie N. A New method for estimating race/ethnicity and associated disparities where administrative records lack self-reported race/ethnicity. Health Serv Res 2008
34. Census Bureau US. A Compass for Understanding and Using American Community Survey Data: What General Data Users Need to Know 2008, Washington, D.C.: U.S. Government Printing Office.
35. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005, 41:281-288. 10.1086/431587, 16007521.
36. Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis 2005, 40:990-996. 10.1086/427690, 15824991.
37. Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am 2001, 15:407-421. vii, 10.1016/S0891-5520(05)70153-7, 11447703.
38. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg 2006, 45:S1-S66. 10.1016/S1067-2516(07)60001-5, 17280936.
39. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003, 26:510-513. 10.2337/diacare.26.2.510, 12547890.
40. Suaya JA, Eisenberg DF, Fang C, Miller LG. Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S. PLoS One 2013, 8:e60057. 10.1371/journal.pone.0060057, 3622669, 23593162.
41. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA 2002, 287:2519-2527. 10.1001/jama.287.19.2519, 12020332.
42. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB, Ferrara A, Liu J, Selby JV. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001, 111:1-9.
43. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997, 20:1396-1402. 10.2337/diacare.20.9.1396, 9283786.
44. Jackson LA. Evaluating diabetes mellitus as a risk factor for community-acquired infections. Clin Infect Dis 2005, 41:289-290. 10.1086/431594, 16007522.
45. Weiss C, Kaminsky P, Boggs J, Ley C. Skin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management. BMC Res Notes 2011, 4:33. 10.1186/1756-0500-4-33, 3044093, 21299887.
46. Jauregui LE, Babazadeh S, Seltzer E, Goldberg L, Krievins D, Frederick M, Krause D, Satilovs I, Endzinas Z, Breaux J, et al. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections. Clin Infect Dis 2005, 41:1407-1415. 10.1086/497271, 16231250.
47. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674. 10.1056/NEJMoa055356, 16914702.
48. Ray GT, Suaya JA, Baxter R. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2013, 76:24-30. 10.1016/j.diagmicrobio.2013.02.020, 23537783.
49. Young DM, Harris HW, Charlebois ED, Chambers H, Campbell A, Perdreau-Remington F, Lee C, Mankani M, Mackersie R, Schecter WP. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 2004, 139:947-951. 10.1001/archsurg.139.9.947, 15381611.
50. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005, 45:311-320. 10.1016/j.annemergmed.2004.10.011, 15726056.
51. Sircar KD, Bancroft E, Nguyen DM, Mascola L. Hospitalization of paediatric patients for methicillin-resistant Staphylococcus aureus skin and soft-tissue infection, 1998-2006. Epidemiol Infect 2010, 138:677-682. 10.1017/S095026880999121X, 19919731.
52. Frei CR, Makos BR, Daniels KR, Oramasionwu CU. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg 2010, 45:1967-1974. 10.1016/j.jpedsurg.2010.05.009, 20920714.
53. Zilberberg MD, Chaudhari P, Nathanson BH, Campbell RS, Emons MF, Fiske S, Hays HD, Shorr AF. Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections. BMC Infect Dis 2012, 12:154. 10.1186/1471-2334-12-154, 3518172, 22784260.
54. Liu C, Graber CJ, Karr M, Diep BA, Basuino L, Schwartz BS, Enright MC, O'Hanlon SJ, Thomas JC, Perdreau-Remington F, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis 2008, 46:1637-1646. 10.1086/587893, 18433335.
55. Sattler CA, Mason EO, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002, 21:910-917. 10.1097/00006454-200210000-00005, 12394811.
56. Bar-Meir M, Tan TQ. Staphylococcus aureus skin and soft tissue infections: Can We anticipate the culture result?. Clin Pediatr (Phila) 2010, 49:432-438.